Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences
Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences
From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent.
From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent.
Pharma Penny Stock Under Rs 50 Jumps After Company Successfully Achieved Certificate of Suitability (CEP) for Metformin Hydrochloride from European Directorate
From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. .
From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. .
Pharma Penny Stock Under Rs 50 In Green After Signing MoU with Respilon Group s.r.o
From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent.
From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent.
Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It?
From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent.
From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent.
Pharma Penny Stock Under Rs 50 in Green After Signing an MoU with Indian Navy (INS Kalinga)
The company has a market cap of over Rs 1,200 crore and has delivered good profit growth of 25 per cent CAGR over the last 5 years.
From Rs 34.51 per share (52-week low) to Rs 38.29 per share, the stock is up by 11 per cent.
Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities
From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent.
From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent.
Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25
From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent.
From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent.
33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23
From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent.
From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent.
Pharma Penny Stock Under Rs 60 Jumps After Reporting a 33 Per Cent Jump In PAT
From Rs 43.42 per share (52-week low) to Rs 55.66 per share, the stock is up by 28.2 per cent.
From Rs 43.42 per share (52-week low) to Rs 55.66 per share, the stock is up by 28.2 per cent.
Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside
From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
Pharma Penny Stock Under Rs 60 in Green After Credit Rating Update; Details Inside
From Rs 43.42 per share (52-week low) to Rs 51.49 per share, the stock is up by 18.60 per cent.
From Rs 43.42 per share (52-week low) to Rs 51.49 per share, the stock is up by 18.60 per cent.
Pharma penny stock under Rs 60 jumps after company received communication from EDQM on CEP filing of Propafenone HCl
From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.
From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.